Linenthal, A.J. : The use of quinidine in the treatment of cardiac arrhythmias. Mod. Concepts of Cardiovas. Dis., 24: 299, 1955.
2.
Garrison, F.H.: An Introduction to the History of Medicine, Ed. 3, p. 292. W. B. Saunders Co., Philadelphia, 1922.
3.
Park, R.: The Epitome of the History of Medicine, Ed. 2, p. 164. F. A. Davis , Philadelphia, Chicago, 1899.
4.
Barba, P.: Vera Praxis ad curationem tertianae. Hispali, 1642.
5.
Castiglioni, A.: A History of Medicine, Ed. 2, p. 559. Translated from the Italian and edited by E. B. Krumbhaar, Alfred Knopf, New York, 1947.
6.
Torti, F.R.: Therapeutice specialis, ad febres periodicas perniciosas, etcModena, 1709.
7.
Castiglioni, A.: A History of Medicine, Ed. 2, p. 744. Translated from the Italian and edited by E. B. Krumbhaar.Alfred Knopf, New York, 1947.
8.
Castiglioni, A.: A History of Medicine, Ed. 2, p. 1059, Translated from the Italian and edited by E. B. Krumbhaar.Alfred Knopf , New York, 1947.
9.
Wenckebach, K.F.: Die unregelmassige Herztatigkeit and ihre klinische Bedeutung, pp. 173-175. W. Engelmann, Leipsig, Berlin, 1914.
10.
Frey, W.: Uber Vorhofflimmern beim Menschen und seine Beseitigung durch Chinidin. Berl., klin. Wchschr., 50: 450-452, 1918.
11.
Bolton, F.G. : Thrombocytopenic purpura due to quinidine. II. Serologic mechanisms. Blood, 11: 547, 1956.
12.
Seyderhelkin. R.: Thrombocytopenic purpura following quinidine . Proc. Med. Gesell. Göttinger klin. Wchnschr., 43: 2065, 1927.
13.
Bolton, F.G. AND Dameshek, W.: Thrombocytopenic purpura due to quinidine, I. Clinical Studies. Blood, 11: 527, 1956.
14.
Hirsch, E.O. AND Dameshek, W.: Thrombocytopenic purpura due to allergy to quinidine. Study of the mechanism of thrombocytopenia. Am. J. Med., 9: 828, 1950.
15.
Barkham, P. AND Tocantins, L.M.: On the thrombocytopenia due to hypersensitivity to quinidine. Blood, 9: 134, 1954.
16.
Bigelow, F.S. AND Desforges, J.F.: Platelet agg'utination by an abnormal plasma factor in thrombocytopenic purpura associated with quinidine poisoning. Am. J. Med. Sc., 224: 274, 1952.
17.
Larson, R.K. : The mechanism of quinidine purpura. Blood, 8: 16, 1953.
18.
Nachlas, N.E. : Thrombocytopenic purpura due to quinidine. A. M. A. Arch Otolaryngol., 62: 591, 1955.
19.
Christensen, R. AND Andreasen, A.P.: Quinidine allergy. Acta. Allergo'ogica, 4: 37, 1951.
20.
Gold, H., Reader, G., et al., A re-evaluation of quinidine therapy. (Conference on Therapy.)Am. J. Med., 17: 395, 1954.
21.
Rose, O.A., Vogl, A. AND Turtz, A.I.: Drug fever due to quinidine. New England J. Med., 248: 96, 1952.
22.
Wallace, J.D. , JR.: Fever due to quinidine, case report and review. North Carolina M. J., 17: 227, 1956.
23.
Siegal, S. AND Horn, H.: Quinidine allergy. Am. Heart J., 39: 303, 1950.
24.
Sprague, H.B. AND Tansey, W.A.: Fever as a sign of quinidine toxicity; report of sensitivity in two brothers with thyroid disease. New England J. Med., 249: 796, 1953.
25.
Stimson, W.H. AND Mckusick, V.A.: Febrile reactions to quinidine, Am. J. Med. Sc., 221: 440, 1951.
26.
Berley, B.S. AND Saland, G.: Febrile sensitivity to quinidine given orally . J. A. M. A., 148: 1121, 1952.
27.
Jackler, J. AND Magendantz, H.: Fever after quinidine medication; report on a case. Bull. New Eng'and Med. Center, 16: 37, 1954.
28.
Snow, J.S.: Drug eruptions. J. M. A. Alabama, 11: 14, 1941.
29.
Goldschlag, F. : A case of drug allergy of both types: fixed and generalized eruptions. M. J. Australia, 2: 501, 1942.
30.
Taylor, D.R. AND Potashnick, R.: Quinidine-induced exfoliative dermatitis, with a brief review of quinidine idiosyncrasies. J. A. M. A., 145: 641, 1951 .
31.
Wechsler, H.L. : Dermatitis medicamentosa ; a lichen-planuslike eruption due to quinidine. A. M. A. Arch. Dermat. & Syph. , 69: 741, 1954.
32.
Gold, H.: Quinidine in Disorders of the Heart. Hoeber, New York, 1950.
33.
Brown, M.G., Holzman, D. AND Creel-Man, E.W.: Serum quinidine concentration in congestive heart failure. Am. J. Med., Sc., 225: 129, 1953.
34.
Kennamer, R. , AND Prinzmetal, M.: The cardiac arrhythmias. New England J. Med., 250: 509, 1954.
35.
Sokolow, M. : The present status of therapy of the cardiac arrhythmias with quinidine. Am. Heart J., 52: 771, 1951.
36.
Clagett, A.H. , JR.: Intravenous use of quinidine with particular reference to ventricular tachycardia. Am. J. M. Sc., 220: 381, 1950.
37.
Harris, A.S. , Estandia, A., Ford, T.J., JR. AND Tillotson , R.F.: Quinidine lactate and gluconate in the suppression of ectopic ventricular tachycardias associated with myocardial infarction; control of toxicity by morphine. Circulation,4: 522, 1951.
38.
Dipalma, J.R. AND Schults, J.E.: Antifibrillatory drugs. Medicine29: 123, 1950.
39.
Daly, R.: The use of quinidine. Practitioner, 166: 609, 1951 .
40.
Finnegan, T.R. AND Trounce, J.R.: Depression of the heart by quinidine and its treatment. Brit. Heart J., 16: 341, 1954.
41.
Narfvinge, L.E.: Acute quinidine poisoning in a three-year old child (with special reference to the electrocardiographic changes). Acta paediat., 39: 262, 1950.
42.
Larimer, R.C. : Thrombocytopinic purpura following quinidine therapy. Canad. M. A. J., 60: 508, 1949.
43.
Linenthal, A.J., Winer, B.M. AND Klay-Man, M.I.: Sinoauricular nodal depression and atrioventricular nodal rhythm due to quinidine. Am. Heart J., 46: 443, 1953.
44.
Mishkin, J.A. : Quinidine in heart disease. GP, 1: 35, 1950.
45.
Dispensatory of the United States, p. 1163, Ed. 25, J. P. Lippincott Company, Philadelphia, 1955.
46.
Winsor, T. AND Khoury, N.J.: Treatment of the cardiac arrhythmias. Postgrad. Med., 19: 101, 1956.
47.
Sokolow, M. AND Ball, R.E.: Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration . Circulation14: 568, 1956.
48.
Kalmansohn, R.W. AND Sampson, J.J.: Studies of plasma quinidine content. II. Relation to toxic manifestations and therapeutic effect. Circulation, 1: 569, 1950.
49.
Weisman, S.A. : Quinidine, "pure quinidine," and hydroquinidine. I. Toxicity. Am. Heart J., 24: 545, 1942.
50.
Berman, R., Sadoff, C.M. AND Gordon, G.B.: Quinidine intoxication occurring during therapy of auricular arrhythmias. Minnesota Med., 36: 1052, 1953.
51.
Blinder, H. , Burstein, J., Horowitz, W., Gersh, E. AND Smelin, R.: Studies on the effects of parenteral quinidine administration. A.M.A. Arch. Int. Med., 86: 917, 1950.
52.
Entwisle, G. : The cardiac arrhythmias: some aspects of treatment. M. Clin. of NorthAmerica, Boston No., p. 1367, Sept. 1955 .
53.
Grodel, F.M. AND Miller, M.: Some gastrointestinal symptoms resulting from cardiac medications. Am. J. Digest. Dis., 17: 154, 1950.
54.
Love, W.D.: The basis of quinidine ther. apy. Am. J. Med. Sc., 229: 89, 1955.
55.
Ernstene, A.C. AND Lewis, S.: The mechanism of vomiting induced by quinidine. I. Quinidine emesis in animals with denervated hearts. J. Pharmacol. & Exper. Therap., 48: 305, 1933.
56.
Ernstene, A.C. AND Lewis, S.: The mechanism of vomiting induced by quinidine: II. J. Pharmacol., & Exper. Therap.48: 359,1933.
57.
Gluck, J.L. , Gold, H., Greiner, T., M-Dell, W., Quit, N.T., Thickman, S., Otto, H.L., AND Warshaw, L.J.: Quinidine sulfate in propylene glycol. by intramuscular injection in man. J. A. M. A., 145: 637, 1951.
Sampson, J.J. , Foreman, H. AND Solomon, B.C.: Studies of plasma quinidine content, III. The value of delayed absorptive coated tablets in oral quinidine therapy. Circulation, 5: 534, 1952.
60.
Berger, H.H. : Parenteral quinidine in the treatment of paroxysmal auricular fibrillation. Am. Heart J., 41: 624, 1951.
61.
Russek, H.I. AND Zohman, B.L.: Paregoric as an antidote for quinidine . J. A. M. A., 147: 1070, 1951.
62.
Russek, H.I. : Hazards in the treatment of acute myocardial infarction. Am. J. Med. Sc., 232: 403, 1956 .
63.
Sturnick, M.I. , Riseman, J.E.F. AND Sagall, E.L.: Studies on the action of quinidine in man . J. A. M. A., 121: 917, 1943.
64.
Ackroyd, J.F. : Platelet agglutinins and lipins in the pathogenesis of thrombocytopenic purpura with a note on platelet groups. Brit M. Bull., 11: 28, 1955.
65.
New and Non-Official Remedies. A. M. A. p. 259, 1956.
66.
Levine, S.A.: Clinical Heart Disease. Ed. 3., pp. 284-291, W. B. Saunders Company, Philadelphia, 1945.
67.
Yount, E.H. AND Rosenblum, M.: Studies of plasma quinidine levels in relation to therapeutic effect and toxic manifestations. Southern M. J., 43: 324, 1950.
68.
Broch, O.J. : Thrombocytopenic purpura after administration of quinidine. Nord. med., 10: 1542, 1941.
69.
Soisala, P. : Thrombocytopenic purpura induced by quinidine . Ann. med. int. Fenniae, 36: 181, 1947.
70.
Burstein, J. , AND Lamburg, B.A.: Thrombocytopenia after quinidine medication . Nord. med., 37: 473, 1948.
71.
Collins, D.C. : Atypical secondary or symtomatic thrombocytopenic purpura developing with use of quinidine sulfate. Circulation , 2: 483, 1950.
72.
Moodie, G.: Thrombocytopenic purpura due to quinidine. Brit. M. J., 2: 553, 1950.
73.
Norcross, J.W. : Quinidine as a cause of thrombocytopenic purpura; report of a case. New England J. Med., 242: 53, 1950.
74.
Andreasen, A.P. AND Christensen, R.: Thrombopenic purpura after quinidine sulfate . Ugesk. f. laeger, 113: 422, 1951.
75.
Lopez Garcia, E. AND Sainz , R.: Thrombocytopenic purpura due to quinidine. Rev. clin. español., 42: 419, 1951.
76.
Phelps, J.E. : Secondary thrombocytopenic purpura following quinidine administration. J. Missouri M. A.,48: 905, 1951.
77.
Akesson, S. : A case of thrombocytopenia after quinidine treatment. Cardiologia, 21: 762, 1952.
78.
Nussbaum, H.E. AND Shulman, M.W.: Thrombocytopenic purpura following quinidine therapy. Ann. Int. Med., 37: 190, 1952.
79.
Lipson, L.: Purpura due to quinidine. N. Y. State J. Med., 52: 586, 1952.
80.
Bolton, F.G. AND Young, R.V.: Observations on cases of thrombocytopenic purpura due to quinine, sulphamezathine, and quinidine. J. Clin. Path., 6: 320, 1953.
81.
Mikes, A.: ACTH therapy of thrombocytopenic purpura caused by quinidine. Sppski Arhiv Za Celokupno Lekarsto, 81: 998, 1953.
82.
Weisfuse, L.Spear, P.W. AND Sosa, M.: Quinidine-induced thrombocytopenic purpura ; report of a fourteenth case and review of clinical and experimental studies . Am. J. Med.,17: 414, 1954.
83.
Westwater, J.O. AND Andonia, A.: Quinidine-induced thrombocytopenic purpura . Bull. Moore-White M. Found., 6: 37, 1955.
84.
Gittler, R.D. , Kissin, M. AND Litwins, J.: Quinidine induced thrombocytopenic purpura complicating Dicumarol therapy. Ann. Int. Med., 42: 1118, 1955.
85.
Freedman, A.L. , Brody, E.A. AND Barr, P.S.: Thrombocytopenic purpura due to quinidine . J. Lab. Clin. Med., 48: 205, 1956.
86.
Sturnick, M.I. : An unusual toxic manifestation of the oral use of quinidine sulfate. Am. Heart. J., 24: 559, 1942.
87.
Bedard, O.: Quinidine in the treatment of auricular fibrillation. Am. J. M. Sc., 227: 530, 1954.
88.
Bernreiter, M. AND Fowler, J.W.: Auricular fibrillation and cardiac failure—its treatment with quinidine sulfate. J. Missouri M. A., 48: 906, 1951.
89.
Cutts, F.B. AND Rapoport, B.: The routine use of quinidine in acute myocardial infraction. New England J. Med., 247: 81, 1952.
90.
Ditlefson, E.M. AND Knutsen, B.: Quinidine treatment in chronic auricular fibrillation. II. Maintained treatment of auricular fibrillation after conversion to sinus rhythm, by means of delayed absorption coated quinidine tablets. Acta med. Scandinav.156: 8, 1956.
91.
France, R.: The use of quinidine in the treatment of cardiac arrhythmias. Am. Pract.,1: 790, 1950.
92.
Pfeiffer, P.H. : The use of quinidine. J. Maine M. A.47: 48, 1956.
93.
Sokolow, M. AND Edgar, A.L.: Blood quinidine concentrations as a guide in the treatment of cardiac arrhythmias. Circulation, 1: 576, 1950.
94.
Estes, J.E.: Personal communication.
95.
Weisman, S.A. : Digitalis in treatment of auricular fibrillation , Tr. Am. Coll. Card., 7: 275, 1957.
96.
Delevitt, H.F. AND Poindexter, C.A.: Quinidine plasma concentrations with particular reference to therapeutically effective levels in two cases of paroxysmal nodal tachycardia. Am. Heart J., 32: 6971946.
97.
Scherf, D.: Treatment of Cardiac Arrhythmias. Circulation, 8: 756, 1953.
98.
Weisman, S.A. : Studies on time required for elimination of quinidine from heart and other organs. Am. Heart J., 20: 21, 1940.
99.
Weiss, S. AND Hatcher, R.A.: Quinidine. J. Pharmacol. & Exper. Therap., 30: 335, 1927.
100.
Hiatt, E.P. AND Quinn, G.P.: The distribution of quinine, quinidine, cinchonine and cinchonidine in fluids and tissues of dogs. J. Pharmacol. & Exper. Therap., 83: 101,1945.
101.
Wegria, R. AND Boyle, M.N.: Correlation between the effect of quinidine sulfate on the heart and its concentration in the blood plasma. Am. J. Med. Sci., 208: 756. 1944.